Risk Stratification Using MEESSI-AHF Scale in ED and Impact on AHF Outcomes
MEESSI
Evaluation of the Impact of the MEESSI-AHF Scale on Decision Making and the Prognosis of Patients Diagnosed With Acute Heart Failure in the Emergency
1 other identifier
interventional
3,200
1 country
19
Brief Summary
Evaluate the impact the application of the MESSI-AHF scale (a risk stratification scale specifically derived and validated in patients diagnosed with acute heart failure, AHF) in decision making (admission vs. discharge) by emergency physicians in emergency departments (ED) and its potential impact on on the short-term prognosis of patients with AHF.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2023
19 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 25, 2023
CompletedFirst Posted
Study publicly available on registry
June 26, 2023
CompletedStudy Start
First participant enrolled
June 27, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedFebruary 28, 2024
May 1, 2023
10 months
May 25, 2023
February 27, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
30-day all cause death
Death for any cause since patient randomization (day 0) to day 30
Through study completion, an avarage of 1 year
Days alive and out of hospital
Number of days with patient staying out of hospital (it can be at home, et residencial nursing house, etc., but not at hospital) from randomization (day 0) to day 30.
Through study completion, an avarage of 1 year
Secondary Outcomes (5)
Composite endpoint withing 30 days after discharge (ED revisit due to AHF, hospitalization due to AHF or all-cause death)
Through study completion, an avarage of 1 year
ED revisit due to AHF within the 30 days after discharge
Through study completion, an avarage of 1 year
Hospitalization due to AHF within the 30 days after discharge
Through study completion, an avarage of 1 year
All-cause death within the 30 days after discharge
Through study completion, an avarage of 1 year
Proportion of patients with AHF managed without hospitalization.
Through study completion, an avarage of 1 year
Other Outcomes (2)
Analysis of causes of overruling
Through study completion, an avarage of 1 year
Sensitivity analysis per protocol
Through study completion, an avarage of 1 year
Study Arms (2)
INTERVENTION
EXPERIMENTALOnce AHF has been diagnosed at ED, and before decision-making about hospitalize/discharge home is taken, physicians will objectively measure the severity of decompensation, based on risk of 30-day death using MEESSI scale. As result, patient can be allocated to low, intermediate, high or very-high risk. For patients classified as low-risk, the propocol recommendation will be discharge patient to home. For patients classified as increased risk (i.e., intermediate, high or very-high risk categories), the protocol recommendation will be to hospitalize patient. Nonetheless, final decission will be left to emergency physician, and overruling (disposition against recommendation) will be allowed. For discharged patients, there is no follow up intervention planned, and it will be based on current centre protocols.For hospitalized patients, department of admission will be based on current centre protocols, with no intervention at this level.
USUAL CARE
NO INTERVENTIONOnce AHF has been diagnosed at ED, emergency physicians will decide patient disposition according to their usual strategies of care, that currently do not include risk stratification. For discharged patients, there is no follow up intervention planned, and it will be based on current centre protocols. For hospitalized patients, department of admission will be based on current centre protocols, with no intervention at this level.
Interventions
Once AHF has been diagnosed at ED, and before decision-making about hospitalize/discharge home is taken, physicians will objectively measure the severity of decompensation, based on risk of 30-day death using MEESSI scale. As result, patient can be allocated to low, intermediate, high or very-high risk. For patients classified as low-risk, the propocol recommendation will be discharge patient to home. For patients classified as increased risk (i.e., intermediate, high or very-high risk categories), the protocol recommendation will be to hospitalize patient. Nonetheless, final decission will be left to emergency physician, and overruling (disposition against recommendation) will be allowed.
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of AHF based on Framinham criteria
- NT-proBNP \>300 pg/mL
- Patient able to consent
You may not qualify if:
- ST-elevation acute coronary syndrome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hospital Clinic of Barcelonalead
- Instituto de Salud Carlos IIIcollaborator
Study Sites (19)
Emergency Department, Hospital de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain
Emergency department
Barcelona, Catalonia, 08036, Spain
Emergency Department, Hospital de Getafe
Getafe, Madrid, Spain
Emergency Department, Hospital de Móstoles
Móstoles, Madrid, Spain
Emergency Department, Hospital de Gandia
Gandia, Valencia, Spain
Emergency Department, Hospital de Albacete
Albacete, Spain
Emergency Department, Hospital Dr. Balmis
Alicante, Spain
Emergency Department, Hospital de Sant Pau
Barcelona, Spain
Emergency Department, Hospital del Mar
Barcelona, Spain
Emergency Department, Hospital Vall d'Hebron
Barcelona, Spain
Hospital Universitario de Burgos
Burgos, Spain
Emergency Department, Hospital La Mancha
Ciudad Real, Spain
Emergency Department, Hospital Dr. Gregorio Marañón
Madrid, Spain
Emergency Department, Hospital Infanta Leonor
Madrid, Spain
Emergency Department, Hospital de Salamanca
Salamanca, Spain
Emergency Department, Hospital Marques de Valdecilla
Santander, Spain
Emergency Department, Hospital Sant Pau i Santa Tecla
Tarragona, Spain
Emergency Department, Hospital Dr. Peset
Valencia, Spain
Emergency Department, Hospital La Fe
Valencia, Spain
Related Publications (6)
Miro O, Rossello X, Gil V, Martin-Sanchez FJ, Llorens P, Herrero-Puente P, Jacob J, Bueno H, Pocock SJ; ICA-SEMES Research Group. Predicting 30-Day Mortality for Patients With Acute Heart Failure in the Emergency Department: A Cohort Study. Ann Intern Med. 2017 Nov 21;167(10):698-705. doi: 10.7326/M16-2726. Epub 2017 Oct 3.
PMID: 28973663RESULTMiro O, Rossello X, Gil V, Martin-Sanchez FJ, Llorens P, Herrero P, Jacob J, Lopez-Grima ML, Gil C, Lucas Imbernon FJ, Garrido JM, Perez-Dura MJ, Lopez-Diez MP, Richard F, Bueno H, Pocock SJ. The Usefulness of the MEESSI Score for Risk Stratification of Patients With Acute Heart Failure at the Emergency Department. Rev Esp Cardiol (Engl Ed). 2019 Mar;72(3):198-207. doi: 10.1016/j.rec.2018.05.002. Epub 2018 Jun 11. English, Spanish.
PMID: 29903688RESULTMiro O, Gil V, Rossello X, Martin-Sanchez FJ, Llorens P, Jacob J, Herrero P, Herrera Mateo S, Richard F, Escoda R, Fuentes M, Martin Mojarro E, Llauger L, Bueno H, Pocock S. Patients with acute heart failure discharged from the emergency department and classified as low risk by the MEESSI score (multiple risk estimate based on the Spanish emergency department scale): prevalence of adverse events and predictability. Emergencias. 2019 Feb;31(1):5-14. English, Spanish.
PMID: 30656867RESULTWussler D, Kozhuharov N, Sabti Z, Walter J, Strebel I, Scholl L, Miro O, Rossello X, Martin-Sanchez FJ, Pocock SJ, Nowak A, Badertscher P, Twerenbold R, Wildi K, Puelacher C, du Fay de Lavallaz J, Shrestha S, Strauch O, Flores D, Nestelberger T, Boeddinghaus J, Schumacher C, Goudev A, Pfister O, Breidthardt T, Mueller C. External Validation of the MEESSI Acute Heart Failure Risk Score: A Cohort Study. Ann Intern Med. 2019 Feb 19;170(4):248-256. doi: 10.7326/M18-1967. Epub 2019 Jan 29.
PMID: 30690646RESULTMiro O, Rossello X, Gil V, Martin-Sanchez FJ, Llorens P, Herrero-Puente P, Jacob J, Pinera P, Mojarro EM, Lucas-Imbernon FJ, Llauger L, Aguera C, Lopez-Diez MP, Valero A, Bueno H, Pocock SJ; ICA-SEMES Research Group. Analysis of How Emergency Physicians' Decisions to Hospitalize or Discharge Patients With Acute Heart Failure Match the Clinical Risk Categories of the MEESSI-AHF Scale. Ann Emerg Med. 2019 Aug;74(2):204-215. doi: 10.1016/j.annemergmed.2019.03.010. Epub 2019 May 27.
PMID: 31147102RESULTRossello X, Bueno H, Gil V, Jacob J, Javier Martin-Sanchez F, Llorens P, Herrero Puente P, Alquezar-Arbe A, Raposeiras-Roubin S, Lopez-Diez MP, Pocock S, Miro O. MEESSI-AHF risk score performance to predict multiple post-index event and post-discharge short-term outcomes. Eur Heart J Acute Cardiovasc Care. 2021 Apr 8;10(2):142-152. doi: 10.1177/2048872620934318.
PMID: 33609116RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Oscar Miro, PhD
Hospital CLinic, Barcelona, Spain
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 25, 2023
First Posted
June 26, 2023
Study Start
June 27, 2023
Primary Completion
April 30, 2024
Study Completion
December 31, 2024
Last Updated
February 28, 2024
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share